Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.50
MCK's Cash to Debt is ranked lower than
61% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.69 vs. MCK: 0.50 )
Ranked among companies with meaningful Cash to Debt only.
MCK' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.54 Max: 3.01
Current: 0.5
0.05
3.01
Equity to Asset 0.16
MCK's Equity to Asset is ranked lower than
92% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.40 vs. MCK: 0.16 )
Ranked among companies with meaningful Equity to Asset only.
MCK' s Equity to Asset Range Over the Past 10 Years
Min: 0.15  Med: 0.26 Max: 0.35
Current: 0.16
0.15
0.35
Interest Coverage 10.04
MCK's Interest Coverage is ranked higher than
58% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.95 vs. MCK: 10.04 )
Ranked among companies with meaningful Interest Coverage only.
MCK' s Interest Coverage Range Over the Past 10 Years
Min: 7.81  Med: 9.11 Max: 12.77
Current: 10.04
7.81
12.77
F-Score: 5
Z-Score: 4.42
M-Score: -2.44
WACC vs ROIC
7.55%
19.48%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 1.86
MCK's Operating margin (%) is ranked lower than
76% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.23 vs. MCK: 1.86 )
Ranked among companies with meaningful Operating margin (%) only.
MCK' s Operating margin (%) Range Over the Past 10 Years
Min: 1.12  Med: 1.64 Max: 1.89
Current: 1.86
1.12
1.89
Net-margin (%) 1.18
MCK's Net-margin (%) is ranked lower than
67% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.84 vs. MCK: 1.18 )
Ranked among companies with meaningful Net-margin (%) only.
MCK' s Net-margin (%) Range Over the Past 10 Years
Min: 0.77  Med: 0.98 Max: 1.16
Current: 1.18
0.77
1.16
ROE (%) 25.99
MCK's ROE (%) is ranked higher than
94% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.90 vs. MCK: 25.99 )
Ranked among companies with meaningful ROE (%) only.
MCK' s ROE (%) Range Over the Past 10 Years
Min: 13.37  Med: 16.25 Max: 19.97
Current: 25.99
13.37
19.97
ROA (%) 4.07
MCK's ROA (%) is ranked higher than
54% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.70 vs. MCK: 4.07 )
Ranked among companies with meaningful ROA (%) only.
MCK' s ROA (%) Range Over the Past 10 Years
Min: 2.79  Med: 4.01 Max: 4.73
Current: 4.07
2.79
4.73
ROC (Joel Greenblatt) (%) 139.02
MCK's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.70 vs. MCK: 139.02 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MCK' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 56.24  Med: 114.43 Max: 182.66
Current: 139.02
56.24
182.66
Revenue Growth (3Y)(%) 15.90
MCK's Revenue Growth (3Y)(%) is ranked higher than
87% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.60 vs. MCK: 15.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MCK' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -3  Med: 10.25 Max: 17.8
Current: 15.9
-3
17.8
EBITDA Growth (3Y)(%) 16.70
MCK's EBITDA Growth (3Y)(%) is ranked higher than
78% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 7.90 vs. MCK: 16.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MCK' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -47.9  Med: 8.95 Max: 146.8
Current: 16.7
-47.9
146.8
EPS Growth (3Y)(%) 10.50
MCK's EPS Growth (3Y)(%) is ranked higher than
50% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.50 vs. MCK: 10.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MCK' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 6.6  Med: 11.95 Max: 116.5
Current: 10.5
6.6
116.5
» MCK's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-07-29)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q2 2015

MCK Guru Trades in Q2 2015

Jim Simons 546,400 sh (New)
Andreas Halvorsen 625,568 sh (New)
Joel Greenblatt 229,882 sh (+13406.58%)
Paul Tudor Jones 6,881 sh (+32.86%)
Pioneer Investments 476,784 sh (+2.02%)
Vanguard Health Care Fund 6,342,800 sh (unchged)
Lee Ainslie Sold Out
Steven Cohen Sold Out
Daniel Loeb Sold Out
Mario Gabelli 17,300 sh (-1.06%)
Scott Black 38,358 sh (-1.08%)
Leon Cooperman 691,603 sh (-1.09%)
Larry Robbins 1,025,749 sh (-17.54%)
Ray Dalio 29,713 sh (-44.27%)
» More
Q3 2015

MCK Guru Trades in Q3 2015

Ken Fisher 6,433 sh (New)
First Pacific Advisors 47,405 sh (New)
Steven Cohen 4,700 sh (New)
Andreas Halvorsen 2,274,228 sh (+263.55%)
Larry Robbins 1,810,249 sh (+76.48%)
Joel Greenblatt 280,458 sh (+22.00%)
Paul Tudor Jones 8,278 sh (+20.30%)
Mario Gabelli 17,700 sh (+2.31%)
Vanguard Health Care Fund 6,471,080 sh (+2.02%)
Pioneer Investments 485,930 sh (+1.92%)
Leon Cooperman Sold Out
Scott Black 38,293 sh (-0.17%)
Jim Simons 535,500 sh (-1.99%)
Ray Dalio 26,713 sh (-10.10%)
» More
Q4 2015

MCK Guru Trades in Q4 2015

George Soros 2,100 sh (New)
John Paulson 8,100 sh (New)
Manning & Napier Advisors, Inc 28,820 sh (New)
Jerome Dodson 80,000 sh (New)
Ray Dalio 41,813 sh (+56.53%)
Andreas Halvorsen 2,761,995 sh (+21.45%)
Larry Robbins 2,192,841 sh (+21.13%)
Vanguard Health Care Fund 6,619,780 sh (+2.30%)
Ken Fisher Sold Out
Jim Simons Sold Out
Steven Cohen Sold Out
First Pacific Advisors 43,865 sh (-7.47%)
Mario Gabelli 13,925 sh (-21.33%)
Pioneer Investments 237,417 sh (-51.14%)
Scott Black 9,446 sh (-75.33%)
Paul Tudor Jones 2,028 sh (-75.50%)
Joel Greenblatt 46,915 sh (-83.27%)
» More
Q1 2016

MCK Guru Trades in Q1 2016

Charles Brandes 42,931 sh (New)
Diamond Hill Capital 1,375 sh (New)
John Buckingham 22,294 sh (New)
Dodge & Cox 2,590 sh (New)
Wallace Weitz 57,675 sh (New)
Steven Cohen 9,200 sh (New)
Arnold Van Den Berg 70,171 sh (New)
Joel Greenblatt 367,238 sh (+682.77%)
John Paulson 62,500 sh (+671.60%)
First Pacific Advisors 90,250 sh (+105.74%)
Manning & Napier Advisors, Inc 42,880 sh (+48.79%)
Vanguard Health Care Fund 7,165,280 sh (+8.24%)
Jerome Dodson 80,000 sh (unchged)
George Soros Sold Out
Andreas Halvorsen Sold Out
Scott Black 9,313 sh (-1.41%)
Mario Gabelli 12,070 sh (-13.32%)
Paul Tudor Jones 1,434 sh (-29.29%)
Larry Robbins 927,411 sh (-57.71%)
Ray Dalio 13,000 sh (-68.91%)
Pioneer Investments 11,804 sh (-95.03%)
» More
» Details

Insider Trades

Latest Guru Trades with MCK

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:NYSE:CAH, NYSE:ABC, NAS:HSIC, OTCPK:SHTDF, OTCPK:SHPMY, NAS:PDCO, OTCPK:MAHLY, NYSE:PBH, NYSE:OMI, OTCPK:UDHCF, OTCPK:SHTPY, NYSE:PMC, OTCPK:SNYR, OTCPK:ANNIF, OTCPK:NPHC, OTCPK:SCVM, OTCPK:FZMD, OTCPK:CTTH » details
Traded in other countries:MCK.Germany, MCK.Mexico,
McKesson Corporation distributes pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs.

McKesson Corporation is a Delaware Corporation. The Company delivers pharmaceuticals, medical supplies and healthcare information technology that make healthcare safer while reducing costs. The Company operates in two segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment and health and beauty care products throughout North America and internationally. This segment provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. This segment also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers through a network of distribution centers within the U.S. In addition, this segment sells financial, operational and clinical solutions for pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services. The McKesson Technology Solutions segment includes McKesson Health Solutions, which includes its InterQual clinical criteria solution, claims payment solutions and network performance tools. This segment also delivers enterprise-wide clinical, patient care, financial, supply chain, strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations. This segment's customers include hospitals, physicians, homecare providers, retail pharmacies and payers from North America. McKesson Distribution Solutions consists of the following businesses: North America pharmaceutical distribution and services, International pharmaceutical distribution and services and Medical Surgical distribution and services. The Company competes with other software services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, payers, care management organizations, hardware vendors and internet-based companies with technology applicable to the healthcare industry.

Ratios

vs
industry
vs
history
P/E(ttm) 19.34
MCK's P/E(ttm) is ranked higher than
67% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.51 vs. MCK: 19.34 )
Ranked among companies with meaningful P/E(ttm) only.
MCK' s P/E(ttm) Range Over the Past 10 Years
Min: 8.17  Med: 18.66 Max: 38.44
Current: 19.34
8.17
38.44
Forward P/E 13.83
MCK's Forward P/E is ranked higher than
50% of the 12 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.12 vs. MCK: 13.83 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 19.10
MCK's PE(NRI) is ranked higher than
71% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.51 vs. MCK: 19.10 )
Ranked among companies with meaningful PE(NRI) only.
MCK' s PE(NRI) Range Over the Past 10 Years
Min: 8.17  Med: 18.31 Max: 33.83
Current: 19.1
8.17
33.83
Price/Owner Earnings (ttm) 35.83
MCK's Price/Owner Earnings (ttm) is ranked lower than
65% of the 26 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.04 vs. MCK: 35.83 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
MCK' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 5.5  Med: 12.56 Max: 37.98
Current: 35.83
5.5
37.98
P/B 4.69
MCK's P/B is ranked lower than
87% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.19 vs. MCK: 4.69 )
Ranked among companies with meaningful P/B only.
MCK' s P/B Range Over the Past 10 Years
Min: 1.31  Med: 2.76 Max: 6.98
Current: 4.69
1.31
6.98
P/S 0.23
MCK's P/S is ranked higher than
85% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.84 vs. MCK: 0.23 )
Ranked among companies with meaningful P/S only.
MCK' s P/S Range Over the Past 10 Years
Min: 0.08  Med: 0.18 Max: 0.32
Current: 0.23
0.08
0.32
PFCF 23.53
MCK's PFCF is ranked lower than
68% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.09 vs. MCK: 23.53 )
Ranked among companies with meaningful PFCF only.
MCK' s PFCF Range Over the Past 10 Years
Min: 4.68  Med: 12.71 Max: 43.64
Current: 23.53
4.68
43.64
POCF 18.07
MCK's POCF is ranked lower than
65% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 15.77 vs. MCK: 18.07 )
Ranked among companies with meaningful POCF only.
MCK' s POCF Range Over the Past 10 Years
Min: 4.23  Med: 10.61 Max: 98.78
Current: 18.07
4.23
98.78
EV-to-EBIT 13.39
MCK's EV-to-EBIT is ranked higher than
64% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.58 vs. MCK: 13.39 )
Ranked among companies with meaningful EV-to-EBIT only.
MCK' s EV-to-EBIT Range Over the Past 10 Years
Min: -864.9  Med: 11.30 Max: 22.5
Current: 13.39
-864.9
22.5
EV-to-EBITDA 10.73
MCK's EV-to-EBITDA is ranked higher than
57% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.13 vs. MCK: 10.73 )
Ranked among companies with meaningful EV-to-EBITDA only.
MCK' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.5  Med: 9.40 Max: 59.7
Current: 10.73
4.5
59.7
PEG 1.24
MCK's PEG is ranked higher than
73% of the 22 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.94 vs. MCK: 1.24 )
Ranked among companies with meaningful PEG only.
MCK' s PEG Range Over the Past 10 Years
Min: 0.16  Med: 1.26 Max: 8.68
Current: 1.24
0.16
8.68
Shiller P/E 36.14
MCK's Shiller P/E is ranked lower than
65% of the 17 Companies
in the Global Medical Distribution industry.

( Industry Median: 29.60 vs. MCK: 36.14 )
Ranked among companies with meaningful Shiller P/E only.
MCK' s Shiller P/E Range Over the Past 10 Years
Min: 14.98  Med: 30.23 Max: 51.97
Current: 36.14
14.98
51.97
Current Ratio 1.11
MCK's Current Ratio is ranked lower than
83% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.56 vs. MCK: 1.11 )
Ranked among companies with meaningful Current Ratio only.
MCK' s Current Ratio Range Over the Past 10 Years
Min: 1.08  Med: 1.26 Max: 1.71
Current: 1.11
1.08
1.71
Quick Ratio 0.63
MCK's Quick Ratio is ranked lower than
85% of the 46 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.04 vs. MCK: 0.63 )
Ranked among companies with meaningful Quick Ratio only.
MCK' s Quick Ratio Range Over the Past 10 Years
Min: 0.52  Med: 0.65 Max: 0.88
Current: 0.63
0.52
0.88
Days Inventory 31.14
MCK's Days Inventory is ranked higher than
74% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 48.45 vs. MCK: 31.14 )
Ranked among companies with meaningful Days Inventory only.
MCK' s Days Inventory Range Over the Past 10 Years
Min: 30.05  Med: 31.77 Max: 33.37
Current: 31.14
30.05
33.37
Days Sales Outstanding 27.28
MCK's Days Sales Outstanding is ranked higher than
78% of the 41 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.08 vs. MCK: 27.28 )
Ranked among companies with meaningful Days Sales Outstanding only.
MCK' s Days Sales Outstanding Range Over the Past 10 Years
Min: 22.03  Med: 26.30 Max: 33.27
Current: 27.28
22.03
33.27
Days Payable 58.14
MCK's Days Payable is ranked lower than
63% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 69.49 vs. MCK: 58.14 )
Ranked among companies with meaningful Days Payable only.
MCK' s Days Payable Range Over the Past 10 Years
Min: 43.59  Med: 50.63 Max: 60.49
Current: 58.14
43.59
60.49

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.60
MCK's Dividend Yield is ranked lower than
87% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.74 vs. MCK: 0.60 )
Ranked among companies with meaningful Dividend Yield only.
MCK' s Dividend Yield Range Over the Past 10 Years
Min: 0.35  Med: 0.61 Max: 1.42
Current: 0.6
0.35
1.42
Dividend Payout 0.11
MCK's Dividend Payout is ranked higher than
94% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.30 vs. MCK: 0.11 )
Ranked among companies with meaningful Dividend Payout only.
MCK' s Dividend Payout Range Over the Past 10 Years
Min: 0.04  Med: 0.13 Max: 2
Current: 0.11
0.04
2
Dividend Growth (3y) 6.30
MCK's Dividend Growth (3y) is ranked lower than
68% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.20 vs. MCK: 6.30 )
Ranked among companies with meaningful Dividend Growth (3y) only.
MCK' s Dividend Growth (3y) Range Over the Past 10 Years
Min: -21.7  Med: 0.00 Max: 44.2
Current: 6.3
-21.7
44.2
Forward Dividend Yield 0.60
MCK's Forward Dividend Yield is ranked lower than
88% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.80 vs. MCK: 0.60 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.11
MCK's Yield on cost (5-Year) is ranked lower than
89% of the 54 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.14 vs. MCK: 1.11 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
MCK' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.64  Med: 1.11 Max: 2.59
Current: 1.11
0.64
2.59
3-Year Average Share Buyback Ratio 0.40
MCK's 3-Year Average Share Buyback Ratio is ranked higher than
74% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.70 vs. MCK: 0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MCK' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -45.6  Med: -0.15 Max: 5.7
Current: 0.4
-45.6
5.7

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.14
MCK's Price/Projected FCF is ranked higher than
72% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.49 vs. MCK: 1.14 )
Ranked among companies with meaningful Price/Projected FCF only.
MCK' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.55  Med: 1.12 Max: 17.04
Current: 1.14
0.55
17.04
Price/DCF (Earnings Based) 1.77
MCK's Price/DCF (Earnings Based) is ranked lower than
63% of the 8 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.66 vs. MCK: 1.77 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.30
MCK's Price/Median PS Value is ranked lower than
70% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.00 vs. MCK: 1.30 )
Ranked among companies with meaningful Price/Median PS Value only.
MCK' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.51  Med: 1.00 Max: 3.31
Current: 1.3
0.51
3.31
Price/Peter Lynch Fair Value 1.09
MCK's Price/Peter Lynch Fair Value is ranked higher than
77% of the 13 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.94 vs. MCK: 1.09 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MCK' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.34  Med: 1.23 Max: 72.67
Current: 1.09
0.34
72.67
Earnings Yield (Greenblatt) (%) 7.52
MCK's Earnings Yield (Greenblatt) (%) is ranked higher than
71% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.27 vs. MCK: 7.52 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MCK' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 4.5  Med: 8.70 Max: 17.6
Current: 7.52
4.5
17.6
Forward Rate of Return (Yacktman) (%) 22.96
MCK's Forward Rate of Return (Yacktman) (%) is ranked higher than
81% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.88 vs. MCK: 22.96 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MCK' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -21.1  Med: 19.80 Max: 93.9
Current: 22.96
-21.1
93.9

More Statistics

Revenue (TTM) (Mil) $190,884
EPS (TTM) $ 9.70
Beta0.95
Short Percentage of Float1.12%
52-Week Range $148.29 - 236.86
Shares Outstanding (Mil)225.02

Analyst Estimate

Mar17 Mar18
Revenue (Mil $) 200,948 209,277
EPS ($) 13.49 15.03
EPS w/o NRI ($) 13.49 15.03
EPS Growth Rate
(3Y to 5Y Estimate)
22.18%
» More Articles for NYSE:MCK

Headlines

Articles On GuruFocus.com
Larry Robbins' Largest 1st-Quarter Sales Jun 08 2016 
Joel Greenblatt Bets on eBay, Intel, Biogen Jun 03 2016 
Beware the Financial Destruction of Overvaluation Jun 02 2016 
Vanguard Health Care Fund Ups Stake in High-Conviction Stocks May 10 2016 
Parnassus Fund Comments on McKesson May 09 2016 
Parnassus Fund First Quarter Commentary May 09 2016 
Wallace Weitz Comments on McKesson Apr 22 2016 
Early Oil Investor Arnold Van Den Berg Keeps Buying Energy Stocks in Q1 Apr 19 2016 
Stocks Trading Below Peter Lynch Earnings Line Mar 01 2016 
A Short-Term Problem Creates Long-Term Opportunity in Lannett Company Jan 12 2016 

More From Other Websites
McKesson Raises View Due to Accounting Changes, Stock Up Jun 30 2016
A top Black Lives' Matter activist who ran for mayor of Baltimore just landed a six-figure job with... Jun 30 2016
McKesson's IT Business to Merge with Change Healthcare Jun 29 2016
McKesson (MCK) Stock Surged Today After Raising Guidance Jun 29 2016
Change Healthcare deal leaves many questions to be answered Jun 29 2016
Term Sheet — Wednesday, June 29 Jun 29 2016
[$$] McKesson Raises Annual Guidance Jun 29 2016
MCKESSON CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 29 2016
8:02 am McKesson --CORRECTION-- McKesson raises 2017 EPS guidance to $13.43-13.93 from $13.30-13.80 Jun 29 2016
McKesson Updates Fiscal 2017 Guidance Jun 29 2016
[$$] McKesson to Separate IT Segment in Venture With Blackstone Jun 28 2016
McKesson's IT unit to merge with Change Healthcare Jun 28 2016
McKesson Corporation -- Moody's affirms McKesson's Baa2 ratings post-IT JV; outlook stable Jun 28 2016
McKesson's Tech Unit To Merge With IT Specialist, Form New Company Jun 28 2016
Change Healthcare merger to create health IT giant Jun 28 2016
[$$] McKesson to Separate IT Unit Jun 28 2016
McKesson Embarks on Transformative Journey with Change Healthcare Jun 28 2016
McKesson to separate IT segment in venture with Blackstone Jun 28 2016
McKesson To Look At Tactical Alternatives For Enterprise Information Solutions Jun 28 2016
McKesson's tech solutions business to merge with Change Healthcare Jun 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)